Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

GLAXO ☆ BSE also on NSE

GLAXOSMITHKLINE PHARMACEUTICAL · code 500660 · INE159A01016 · Pharma & Healthcare · series A · Daily price history

2,714.65 +76.65 (+2.91%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
78

ISA Signal Score: Strong setup

Buy candidate: research it further. Based on prices to 2026-11-19. Confidence 80%.

Trend90
Momentum82
52-week range61
Volume68
Risk71

Working for it

  • Price is above its 20-day average
  • Price is above its 50-day average
  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • RSI 58: healthy strength
  • MACD is positive and strengthening

Working against it

  • 50-day average is falling

Measured reference levels (not forecasts): 20-day low 2,404.80, 52-week high 3,106.10, typical daily move 89.96, two typical moves below price 2,534.74.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityNot knownNeeds the yearly results. They load from NSE on their own for NSE stocks.
GrowthNot knownNeeds the yearly results.
ValuationNot knownNeeds EPS from the yearly results.
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 9.9 points
RiskMediumSwings 28% a year, fell up to 23% from a peak, beta 0.47

Smart Investor Tips: GLAXO

Constructive Setup (Trend + Fundamentals Aligned)

Actionable Insights & Positives

  • Confirmed uptrend: trading above both rising 50-day (Rs 2,669.75) and 200-day (Rs 2,530.76) averages.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

BSE Authentic Bhavcopy & Cross-Exchange Check No API Key

Runs authentic BSE price & volume verification (latest BSE Bhavcopy snapshot, split-adjusted 52W High/Low, 20/50/200 DMA alignment, and 20-day volume trend, plus cross-listed NSE MCP check when shared by ISIN).

Algorithmic Buy / Sell Prediction & Optimal Entry PriceBUY / ACCUMULATE IN ZONE (Score 82/100)

Strong technical, volume & cash-flow setup. Best buy zone: Rs 2,629.70 – Rs 2,687.50 (Ideal entry ~Rs 2,658.60). Stagger 50% near Rs 2,687.50 and 50% near Rs 2,629.70. Stop-loss / review below Rs 2,382.87; Swing Target Rs 3,154.91 (R:R 1.8x).

Optimal Buy ZoneTranche 1 (50%)Tranche 2 (50%)Stop-Loss / ReviewTarget 1 (Swing)Target 2 (Breakout)Risk : Reward
Rs 2,629.70 – Rs 2,687.50
Ideal ~Rs 2,658.60
Rs 2,687.50 Rs 2,629.70 Rs 2,382.87
ATR 3.3%
Rs 3,154.91 Rs 3,485.79 1 : 1.8
RSI 64 · Vol 1.42x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +13.6% · high 3,121.10 · low 2,088.00 · max drawdown -22.6%

Live Candlestick & TradingView Chart (GLAXO)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures

P/E-price / earnings
P/B-price / book value
EPS-earnings per share
Dividend yield-from saved dividend events
Debt to equity-borrowings / equity
Sales growth-yearly, needs 2+ years
Profit growth-yearly, needs 2+ years
Operating margin-EBITDA / sales

Yearly results have not loaded yet. They are read from the official NSE results filings on their own; open this page again in a minute.

About GLAXOSMITHKLINE PHARMACEUTICAL

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed15 Dec 2000BSE not available · NSE 15 Dec 2000
Face valueRs 10
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Not checked yet.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 75.00% 0.00 pp, public 25.00%, as on 30 Sep 2026. Holder names and history

Day range2,602.80 to 2,718.20Open 2,640.65
52-week high3,121.10 -13.0% from high (28 Aug 2026)
52-week low2,088.00 +30.0% from low (12 Jun 2026)
Volume6,085 0.6x the 20-day average
RSI (14)58 neutral
Volatility (30d)34.8%annualised
2,088.00
3,121.10

Returns

1W+2.2%
1M+9.0%
3M-9.5%
6M+17.0%
1Y+7.8%
YTD+9.9%
3Y a year+19.9%
5Y a year+10.7%

Against the NIFTY 50

PeriodGLAXONIFTY 50Difference
1M+9.0%+11.5% -2.4 pts
3M-9.5%+5.3% -14.8 pts
6M+17.0%+7.9% +9.1 pts
1Y+7.8%-2.1% +9.9 pts

Risk over the past year

Volatility28%medium
Deepest fall-22.6%from a peak
Beta0.47moves less than the index
Best day+7.4%09 Nov 2026
Worst day-4.5%07 Oct 2026
Up days53%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Jun 2024 Sep 2024 Dec 2024 Jun 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 8111,0009468051,0419959381,184
Sales QoQ % -11.0%+23.3%-5.4%-14.9%+29.3%-4.4%-5.7%+26.1%
Operating Profit 229324290295421387339475
Operating Margin (OPM %) 28.3%32.4%30.7%36.6%40.5%38.9%36.2%40.1%
Net Profit (PAT) 182249229205296278237336
Profit QoQ % -5.9%+36.9%-8.1%-10.3%+44.2%-6.0%-14.6%+41.6%
Profit YoY % --+402.5%+12.9%+29.3%+11.7%+15.7%+63.8%
Net Margin % 22.4%24.9%24.2%25.5%28.4%27.9%25.3%28.4%

Financials

Yearly results have not loaded yet.

They are read from the official NSE results filings (XBRL) on their own when this page opens: the newest year first, then up to 5 years over the next visits. If NSE cannot be reached from your host, the line under the company facts says so.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
ALIVUSALIVUS LIFE SCIENCES LIMITED 1,449.85 +0.3% - 17,768 37.7 7.6 20.2% 20.6%
ASTRAZENASTRAZENECA PHARMA INDIA LTD. 6,120.45 +1.9% - 15,301 94.7 21.5 22.7% 12.5%
AARTIPHARMAarti Pharmalabs Limited 1,024.80 +1.3% - 9,287 42.8 5.3 12.3% 11.7%
BLUEJETBlue Jet Healthcare Limited 516.80 -0.2% - 8,964 54.7 10.6 19.4% 23.0%
CIPLACIPLA LTD. 1,416.00 -0.3% - - - - - -
ALKEMAlkem Laboratories Limited 5,145.00 -1.1% - - 26.7 - 17.0% 16.0%
DIVISLABDIVIS LABORATORIES LTD. 11,178.00 +1.0% - - - - - -
WOCKPHARMAWOCKHARDT LTD. 2,186.60 +7.9% - - - - - -
RUBICONRUBICON RESEARCH LIMITED 1,726.00 +3.9% - - - - - -
APOLLOHOSPAPOLLO HOSPITALS ENTERPRISE LT 8,744.80 -0.8% - - 64.8 - 21.1% 7.9%
RAINBOWRainbow Children's Medicare Li 1,241.45 -1.3% - - - - - -
GLANDGland Pharma Limited 3,291.05 +1.9% - - - - - -
GLAXOGLAXOSMITHKLINE PHARMACEUTICAL 2,714.65 +2.9% - - - - - -
Sector median- 48.89.118.2%

The 13 largest of 80 stocks in this sector on BSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is above its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is above its 200-day average (long-term uptrend) RSI 58: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the upper half of its 1-year range and is lower than it was on 14% of days in the past year.

Support (prices below today's)

50-day average2,669.75-1.7%
200-day average2,530.76-6.8%
20-day low2,342.70-13.7%
60-day low2,342.70-13.7%
52-week low2,088.00-23.1%

Resistance (prices above today's)

20-day high2,770.00+2.0%
60-day high3,121.10+15.0%
52-week high3,121.10+15.0%

Zones buyers often watch

Lower quarter of the 1-year range 2,088.00 to 2,346.28 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 2,496.88 to 2,808.99 price is inside this zone now
Around the 200-day average 2,454.84 to 2,606.68 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -22.6%. Currently -12.6% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average2,569.47 Price is 5.7% above
50-day average2,669.75 Price is 1.7% above
200-day average2,530.76 Price is 7.3% above
RSI (14)58Neutral
MACD (12, 26, 9)18.19Above its signal line (momentum rising)
Volatility (30d)34.8%Medium yearly swings

Support and resistance

R22,793.95
R12,754.30
Pivot2,678.55
S12,638.90
S22,563.15

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 2,640.65 2,718.20 2,602.80 2,714.65 +2.91% 6,085
2026-11-18 2,685.00 2,696.00 2,626.90 2,638.00 -2.06% 5,449
2026-11-17 2,680.00 2,718.60 2,664.25 2,693.55 +1.68% 7,162
2026-11-16 2,693.55 2,693.55 2,638.10 2,649.00 -0.77% 4,651
2026-11-13 2,635.00 2,706.00 2,635.00 2,669.55 +0.54% 4,480
2026-11-12 2,715.00 2,732.85 2,653.35 2,655.30 -2.61% 4,104
2026-11-11 2,749.90 2,770.00 2,675.00 2,726.40 +0.57% 9,488
2026-11-09 2,580.00 2,754.00 2,567.80 2,710.85 +6.77% 35,096
2026-11-06 2,515.80 2,542.90 2,494.25 2,524.85 +0.97% 38,527
2026-11-05 2,550.00 2,570.55 2,495.55 2,500.70 -1.26% 54,969
2026-11-04 2,624.80 2,624.80 2,494.05 2,532.60 -1.58% 5,885
2026-11-03 2,565.25 2,604.90 2,547.70 2,573.30 +1.78% 2,434
2026-11-02 2,512.05 2,578.95 2,512.00 2,528.35 +1.80% 2,845
2026-10-30 2,526.15 2,528.85 2,480.00 2,483.55 -1.28% 1,795
2026-10-29 2,505.90 2,540.00 2,497.80 2,515.65 +0.76% 2,210
2026-10-28 2,451.50 2,512.75 2,443.55 2,496.65 +0.32% 1,048
2026-10-27 2,461.15 2,517.00 2,445.55 2,488.75 +1.66% 4,368
2026-10-26 2,387.55 2,451.00 2,387.55 2,448.15 +1.80% 2,133
2026-10-23 2,420.15 2,423.60 2,342.70 2,404.80 -1.23% 3,432
2026-10-22 2,455.50 2,456.25 2,425.00 2,434.70 -1.18% 1,430
2026-10-21 2,469.80 2,509.00 2,446.45 2,463.75 -1.04% 2,472
2026-10-19 2,575.00 2,575.00 2,475.00 2,489.70 -2.94% 1,124
2026-10-16 2,527.25 2,572.40 2,527.25 2,565.20 +1.67% 2,374
2026-10-15 2,550.00 2,550.00 2,489.60 2,523.00 -0.65% 4,197
2026-10-14 2,531.00 2,547.40 2,502.95 2,539.40 +0.21% 1,248
2026-10-13 2,523.00 2,545.00 2,496.00 2,534.00 +0.10% 2,334
2026-10-12 2,541.05 2,554.75 2,522.00 2,531.40 -0.33% 1,545
2026-10-09 2,510.25 2,563.90 2,489.00 2,539.80 +0.20% 3,495
2026-10-08 2,640.00 2,640.00 2,529.00 2,534.65 -3.74% 2,786
2026-10-07 2,709.20 2,777.20 2,616.00 2,633.25 -4.53% 6,931
2026-10-06 2,720.80 2,764.00 2,709.00 2,758.10 +0.87% 1,517
2026-10-05 2,770.00 2,785.30 2,720.00 2,734.25 -1.45% 2,836
2026-10-01 2,770.00 2,796.10 2,725.00 2,774.50 +0.25% 3,797
2026-09-30 2,752.65 2,810.00 2,752.65 2,767.60 -0.70% 2,578
2026-09-29 2,880.05 2,893.70 2,775.00 2,787.25 -3.82% 3,692
2026-09-28 2,812.00 2,986.65 2,788.80 2,897.85 +2.88% 14,107
2026-09-25 2,834.10 2,834.10 2,805.60 2,816.85 -0.31% 639
2026-09-24 2,878.05 2,878.05 2,821.00 2,825.75 -1.76% 1,674
2026-09-23 2,860.00 2,920.25 2,842.90 2,876.50 +0.17% 35,527
2026-09-22 2,859.90 2,880.00 2,842.00 2,871.50 +0.26% 2,208
2026-09-21 2,846.10 2,875.00 2,837.95 2,863.95 +0.42% 3,091
2026-09-18 2,800.45 2,890.00 2,800.45 2,851.85 +1.84% 6,433
2026-09-17 2,848.35 2,848.40 2,795.00 2,800.45 -1.87% 747
2026-09-16 2,807.00 2,880.00 2,758.35 2,853.85 +1.41% 4,902
2026-09-15 2,802.05 2,840.30 2,775.10 2,814.10 -0.81% 2,588
2026-09-11 2,848.95 2,862.40 2,787.80 2,837.20 -0.13% 3,760
2026-09-10 2,883.35 2,960.00 2,836.25 2,840.80 -1.57% 2,065
2026-09-09 2,930.00 2,959.55 2,872.90 2,886.15 -1.45% 3,416
2026-09-08 2,941.85 3,000.30 2,924.60 2,928.70 -0.96% 1,897
2026-09-07 2,932.10 3,074.00 2,932.10 2,956.95 -0.06% 24,980
2026-09-04 2,965.55 2,965.55 2,930.00 2,958.60 +0.79% 1,734
2026-09-03 2,946.65 2,998.80 2,929.40 2,935.35 -0.38% 2,151
2026-09-02 2,990.00 2,990.00 2,908.75 2,946.60 -1.61% 3,317
2026-09-01 3,004.70 3,034.15 2,967.05 2,994.70 -1.91% 2,956
2026-08-31 3,120.60 3,120.60 3,040.10 3,053.10 -1.71% 3,431
2026-08-28 3,082.05 3,121.10 3,066.00 3,106.10 +1.23% 2,423
2026-08-27 3,027.50 3,116.10 3,018.70 3,068.35 +1.35% 6,205
2026-08-26 2,998.80 3,048.90 2,973.50 3,027.50 +1.59% 68,949
2026-08-25 2,929.60 3,006.00 2,920.55 2,980.05 +1.69% 235,095
2026-08-24 2,897.85 2,951.00 2,871.05 2,930.50 +1.07% 3,455
2026-08-21 2,979.25 2,992.55 2,875.00 2,899.60 -3.35% 6,539
2026-08-20 3,007.40 3,040.00 2,985.00 2,999.95 -1.12% 17,359
2026-08-19 2,854.85 3,051.00 2,854.85 3,034.05 +5.23% 99,093
2026-08-18 2,675.65 2,918.00 2,675.65 2,883.20 +6.79% 21,867
2026-08-17 2,688.00 2,709.85 2,660.75 2,699.80 +0.40% 4,014
2026-08-14 2,660.00 2,695.00 2,649.30 2,689.10 +0.92% 3,397
2026-08-13 2,607.10 2,679.90 2,605.05 2,664.65 +1.72% 5,316
2026-08-12 2,601.00 2,625.10 2,581.00 2,619.65 +0.87% 813
2026-08-11 2,609.85 2,614.05 2,577.90 2,596.95 -0.16% 2,882
2026-08-10 2,590.00 2,612.95 2,588.30 2,601.00 +0.31% 889
2026-08-07 2,584.60 2,624.50 2,538.50 2,593.05 +0.52% 4,070
2026-08-06 2,548.65 2,592.60 2,538.00 2,579.60 +0.51% 1,288
2026-08-05 2,645.00 2,645.00 2,508.50 2,566.55 -3.06% 4,678
2026-08-04 2,680.00 2,680.00 2,611.60 2,647.45 -0.37% 2,388
2026-08-03 2,684.60 2,684.60 2,634.25 2,657.20 +0.14% 4,301
2026-07-31 2,618.00 2,675.00 2,567.05 2,653.45 +1.68% 2,858
2026-07-30 2,609.95 2,636.00 2,590.00 2,609.65 -0.67% 2,303
2026-07-29 2,641.85 2,665.00 2,600.10 2,627.35 -0.52% 6,448
2026-07-28 2,541.50 2,675.10 2,541.50 2,641.20 +3.57% 4,963
2026-07-27 2,554.65 2,560.00 2,494.70 2,550.20 +1.47% 2,697
2026-07-24 2,494.20 2,525.80 2,455.00 2,513.25 +0.76% 3,064
2026-07-23 2,599.80 2,599.80 2,490.65 2,494.20 -2.23% 3,198
2026-07-22 2,503.95 2,562.00 2,463.95 2,551.10 +1.83% 4,731
2026-07-21 2,473.75 2,509.35 2,467.90 2,505.30 +0.79% 3,412
2026-07-20 2,469.10 2,499.00 2,447.25 2,485.65 +1.25% 5,238
2026-07-17 2,492.45 2,509.90 2,431.00 2,455.05 -2.06% 3,304
2026-07-16 2,482.00 2,509.90 2,465.40 2,506.70 +0.85% 3,034
2026-07-15 2,427.80 2,498.00 2,427.80 2,485.65 +0.90% 4,764
2026-07-14 2,412.55 2,525.00 2,412.55 2,463.55 +1.91% 9,059
2026-07-13 2,440.00 2,440.00 2,408.75 2,417.30 -0.75% 3,192
2026-07-10 2,434.40 2,454.00 2,422.55 2,435.50 -0.31% 2,897
2026-07-09 2,409.90 2,460.00 2,395.75 2,443.10 +1.38% 3,459
2026-07-08 2,390.95 2,431.55 2,390.10 2,409.90 +0.29% 6,361
2026-07-07 2,417.55 2,417.55 2,388.70 2,402.90 +0.10% 4,333
2026-07-06 2,393.00 2,405.75 2,370.65 2,400.60 +0.33% 183,948
2026-07-03 2,415.00 2,425.00 2,377.85 2,392.75 -0.96% 4,148
2026-07-02 2,447.75 2,465.90 2,406.10 2,415.95 -1.93% 4,167
2026-07-01 2,470.60 2,508.35 2,424.85 2,463.40 +0.51% 10,434
2026-06-30 2,387.15 2,461.00 2,336.10 2,450.90 +4.09% 18,320
2026-06-29 2,343.25 2,406.50 2,343.25 2,354.65 -0.18% 7,051
2026-06-25 2,354.50 2,387.85 2,334.35 2,358.85 +0.18% 6,616
2026-06-24 2,399.95 2,399.95 2,343.65 2,354.50 -1.81% 11,064
2026-06-23 2,365.60 2,403.25 2,354.20 2,397.90 +1.37% 23,015
2026-06-22 2,363.00 2,376.50 2,320.70 2,365.55 +1.40% 13,190
2026-06-19 2,266.85 2,349.00 2,239.00 2,332.85 +2.91% 26,977
2026-06-18 2,214.30 2,274.75 2,192.05 2,266.85 +3.09% 57,756
2026-06-17 2,209.95 2,210.00 2,170.00 2,198.85 -0.10% 8,187
2026-06-16 2,129.05 2,207.00 2,126.80 2,201.15 +3.60% 29,606
2026-06-15 2,159.85 2,171.80 2,111.00 2,124.65 +0.19% 8,207
2026-06-12 2,125.90 2,130.60 2,088.00 2,120.70 +0.86% 353,278
2026-06-11 2,158.90 2,168.90 2,096.65 2,102.70 -3.29% 4,881
2026-06-10 2,214.80 2,214.80 2,164.80 2,174.30 -0.92% 3,639
2026-06-09 2,191.00 2,214.40 2,186.00 2,194.55 +0.51% 4,327
2026-06-08 2,160.20 2,189.60 2,136.05 2,183.50 +0.79% 7,356
2026-06-05 2,166.50 2,184.95 2,160.50 2,166.30 -0.01% 2,381
2026-06-04 2,177.35 2,189.00 2,164.00 2,166.50 -0.60% 1,522
2026-06-03 2,199.25 2,199.25 2,167.10 2,179.65 -0.40% 1,887
2026-06-02 2,203.70 2,203.70 2,155.00 2,188.30 -0.70% 4,950
2026-06-01 2,208.25 2,217.25 2,184.00 2,203.65 -0.23% 5,107
2026-05-29 2,252.80 2,265.00 2,194.15 2,208.70 -4.01% 12,020
2026-05-27 2,289.05 2,314.90 2,283.00 2,301.05 +0.78% 10,679
2026-05-26 2,305.00 2,312.10 2,279.00 2,283.15 -0.74% 12,265
2026-05-25 2,346.00 2,346.00 2,296.30 2,300.10 -0.42% 10,442
2026-05-22 2,324.65 2,344.00 2,295.00 2,309.80 -0.47% 5,733
2026-05-21 2,371.20 2,377.00 2,312.40 2,320.75 -1.14% 5,075
2026-05-20 2,390.00 2,395.80 2,343.60 2,347.60 -1.73% 4,685
2026-05-19 2,389.00 2,421.90 2,381.00 2,388.90 -0.01% 2,445
2026-05-18 2,435.05 2,435.05 2,372.10 2,389.25 -2.07% 4,821

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 15 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: GLAXOSMITHKLINE PHARMA LT, ISIN INE159A01016.

Promoters and group
75.00%
0.00 pp vs Jun 2026
Public (all, Category B)
25.00%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group75.00%75.00%0.00 pp-0.00 ppNo material change.
Public (all, Category B)25.00%25.00%0.00 pp-0.00 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

The exchange listing has no filing file for this stock, so holder names are not available.

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202675.00%0.00 pp25.00%0.00 pp15 Oct 2026NSE
Jun 202675.00%0.00 pp25.00%0.00 pp16 Jul 2026NSE
Mar 202675.00%0.00 pp25.00%0.00 pp10 Apr 2026NSE
Dec 202575.00%0.00 pp25.00%0.00 pp09 Jan 2026NSE
Sep 202575.00%0.00 pp25.00%0.00 pp08 Oct 2025NSE
Jun 202575.00%0.00 pp25.00%0.00 pp15 Jul 2025NSE
Mar 202575.00%0.00 pp25.00%0.00 pp17 Apr 2025NSE
Dec 202475.00%0.00 pp25.00%0.00 pp14 Jan 2025NSE
Sep 202475.00%0.00 pp25.00%0.00 pp04 Oct 2024NSE
Jun 2024 revised75.00%0.00 pp25.00%0.00 pp05 Jul 2024NSE
Mar 202475.00%0.00 pp25.00%0.00 pp04 Apr 2024NSE
Dec 202375.00%0.00 pp25.00%0.00 pp08 Jan 2024NSE
Sep 202375.00%0.00 pp25.00%0.00 pp09 Oct 2023NSE
Jun 202375.00%0.00 pp25.00%0.00 pp14 Jul 2023NSE
Mar 202375.00%0.00 pp25.00%0.00 pp11 Apr 2023NSE
Dec 202275.00%0.00 pp25.00%0.00 pp12 Jan 2023NSE
Sep 202275.00%0.00 pp25.00%0.00 pp19 Oct 2022NSE
Jun 202275.00%0.00 pp25.00%0.00 pp09 Jul 2022NSE
Mar 202275.00%0.00 pp25.00%0.00 pp11 Apr 2022NSE
Dec 202175.00%0.00 pp25.00%0.00 pp07 Jan 2022NSE
Sep 202175.00%-25.00%-08 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

BSE events come from the BSE corporate actions file, which an admin uploads. There is no automatic BSE fetch. Nothing has been imported for this stock yet.

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.